The clinicopathological significance and relationship of Gli1, MDM2 and p53 expression in resectable pancreatic cancer

Histopathology

Volumn 64, Issue 4, 2014, Pages 523-535

  Sheng, Weiwei ^a   Dong, Ming ^a   Zhou, Jianping ^a   Li, Xin ^a   Liu, Qingfeng ^b   Dong, Qi ^b   Li, Feng ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

^b People's Hospital of Liaoning Province   (China)

Author keywords

Gli1; MDM2; P53; Pancreatic cancer; Prognosis; RNA interference

Indexed keywords

GLI1; MDM2; P53; PANCREATIC CANCER; PROGNOSIS; RNA INTERFERENCE;

ADULT; AGED; CARCINOMA, PANCREATIC DUCTAL; CELL LINE, TUMOR; EIF-2 KINASE; FEMALE; GENE EXPRESSION; GENE KNOCKDOWN TECHNIQUES; GENES, P53; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; MALE; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; MUTATION; NEOPLASM INVASIVENESS; PANCREATIC NEOPLASMS; PROGNOSIS; PROTO-ONCOGENE PROTEINS C-AKT; PROTO-ONCOGENE PROTEINS C-MDM2; RNA, SMALL INTERFERING; TRANSCRIPTION FACTORS; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84895071026     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/his.12273     Document Type: Article

References (32)

1. Fry LC, Mönkemüller K, Malfertheiner P. Molecular markers of pancreatic cancer: development and clinical relevance. Langenbecks Arch. Surg. 2008; 393; 883-890.
2. Pasca di Magliano M, Hebrok M. Hedgehog signalling in cancer formation and maintenance. Nat. Rev. Cancer 2003; 3; 903-911.
3. Nagai S, Nakamura M, Yanai K et al. Gli1 contributes to the invasiveness of pancreatic cancer through matrix metalloproteinase-9 activation. Cancer Sci. 2008; 99; 1377-1384.
4. Fernández-Zapico ME. Primers on molecular pathways GLI: more than just Hedgehog? Pancreatology 2008; 8; 227-229.
5. Kinzler KW, Ruppert JM, Bigner SH et al. The GLI gene is a member of the Kruppel family of zinc finger proteins. Nature 1988; 332; 371-374.
6. Rossi M, Magnoni L, Miracco C et al. β-Catenin and Gli1 are prognostic markers in glioblastoma. Cancer Biol. Ther. 2011; 11; 753-761.
7. Nilsson M, Undèn AB, Krause D et al. Induction of basal cell carcinomas and trichoepitheliomas in mice overexpressing GLI-1. Proc. Natl Acad. Sci. USA 2000; 97; 3438-3443.
8. Kimura H, Stephen D, Joyner A et al. Gli1 is important for medulloblastoma formation in Ptc1 +/- mice. Oncogene 2005; 24; 4026-4036.
9. Karhadkar SS, Bova GS, Abdallah N et al. Hedgehog signalling in prostate regeneration, neoplasia and metastasis. Nature 2004; 431; 707-712.
10. Xu L, Kwon YJ, Frolova N et al. Gli1 promotes cell survival and is predictive of a poor outcome in ERalpha-negative breast cancer. Breast Cancer Res. Treat. 2010; 123; 59-71.
11. Nolan-Stevaux O, Lau J, Truitt ML et al. GLI1 is regulated through Smoothened-independent mechanisms in neoplastic pancreatic ducts and mediates PDAC cell survival and transformation. Genes Dev. 2009; 23; 24-36.
12. Dong M, Nio Y, Yamasawa K et al. p53 alteration is not an independent prognostic indicator, but affects the efficacy of adjuvant chemotherapy in human pancreatic cancer. J. Surg. Oncol. 2003; 82; 111-120.
13. Yamasawa K, Nio Y, Dong M et al. Clinicopathological significance of abnormalities in Gadd45 expression and its relationship to p53 in human pancreatic cancer. Clin. Cancer Res. 2002; 8; 2563-2569.
14. Stecca B, Ruizi Altaba A. A GLI1-p53 inhibitory loop controls neural stem cell and tumor cell numbers. EMBO J. 2009; 28; 663-676.
15. Clement V, Sanchez P, de Tribolet N et al. HEDGEHOG-GLI1 signaling regulates human glioma growth, cancer stem cell self-renewal, and tumorigenicity. Curr. Biol. 2007; 17; 165-172.
16. Dong M, Ma G, Tu W et al. Clinicopathological significance of p53 and mdm2 protein expression in human pancreatic cancer. World J. Gastroenterol. 2005; 11; 2162-2165.
17. Michael D, Oren M. The p53-Mdm2 module and the ubiquitin system. Semin. Cancer Biol. 2003; 13; 49-58.
18. Malek R, Matta J, Taylor N et al. The p53 inhibitor MDM2 facilitates Sonic Hedgehog-mediated tumorigenesis and influences cerebellar foliation. PLoS One 2011; 6; e17884.
19. Barton CM, Staddon SL, Hughes CM et al. Abnormalities of the p53 tumour suppressor gene in human pancreatic cancer. Br. J. Cancer 1991; 64; 1076-1082.
20. Masunaga R, Kohno H, Dhar DK et al. Cyclooxygenase-2 expression correlates with tumor neovascularization and prognosis in human colorectal carcinoma patients. Clin. Cancer Res. 2000; 6; 4064-4068.
21. Li YC, Deng YH, Guo ZH et al. Prognostic value of hedgehog signal component expression in hepatoblastoma patients. Eur. J. Med. Res. 2010; 15; 468-474.
22. Chung CH, Dignam JJ, Hammond ME et al. Glioma-associated oncogene family zinc finger 1 expression and metastasis in patients with head and neck squamous cell carcinoma treated with radiation therapy (RTOG 9003). J. Clin. Oncol. 2011; 29; 1326-1334.
23. Qiu SJ, Ye SL, Wu ZQ et al. The expression of the mdm2 gene may be related to the aberration of the p53 gene in human hepatocellular carcinoma. J. Cancer Res. Clin. Oncol. 1998; 124; 253-258.
24. Shi W, Meng Z, Chen Z et al. RNA interference against MDM2 suppresses tumor growth and metastasis in pancreatic carcinoma SW1990HM cells. Mol. Cell. Biochem. 2011; doi: 10.1007/s11010-011-1208-4.
25. Munro AJ, Lain S, Lane DP. P53 abnormalities and outcomes in colorectal cancer: a systematic review. Br. J. Cancer 2005; 92; 434-444.
26. Yokoyama M, Yamanaka Y, Friess H et al. p53 expression in human pancreatic cancer correlates with enhanced biological aggressiveness. Anticancer Res. 1994; 14; 2477-2483.
27. Moskovits N, Kalinkovich A, Bar J et al. p53 Attenuates cancer cell migration and invasion through repression of SDF-1/CXCL12 expression in stromal fibroblasts. Cancer Res. 2006; 66; 10671-10676.
28. Wu X, Bayle JH, Olson D et al. The p53-mdm-2 autoregulatory feedback loop. Genes Dev. 1993; 7; 1126-1132.
29. Abe Y, Oda-Sato E, Tobiume K et al. Hedgehog signaling overrides p53-mediated tumor suppression by activating Mdm2. Proc. Natl Acad. Sci. USA 2008; 105; 4838-4843.
30. Sui X, Shin S, Zhang R et al. Hdm2 is regulated by K-Ras and mediates p53-independent functions in pancreatic cancer cells. Oncogene 2009; 28; 709-720.
31. Lu JT, Zhao WD, He W et al. Hedgehog signaling pathway mediates invasion and metastasis of hepatocellular carcinoma via ERK pathway. Acta Pharmacol. Sin. 2012; 33; 691-700.
32. Singh RR, Cho-Vega JH, Davuluri Y et al. Sonic hedgehog signaling pathway is activated in ALK-positive anaplastic large cell lymphoma. Cancer Res. 2009; 69; 2550-2558.